| 更新日期 | 產(chǎn)品編號(hào) | 品牌 | 產(chǎn)品信息 | CAS號(hào) | MDL號(hào) | 規(guī)格與純度 | 包裝 | 價(jià)格 | 庫存信息 | 操作 |
|
2026/06/05
|
HY-P9981
|
|
Tafasitamab
|
1422527-84-1
|
|
|
1 mg
|
4000元
|
In-stock
|
詳細(xì)
|
|
2025/05/22
|
HY-P9981
|
|
Tafasitamab
|
1422527-84-1
|
|
|
5 mg
|
10500元
|
In-stock
|
詳細(xì)
|
|
2025/05/22
|
HY-P9981
|
|
TAFASITAMAB (ANTI-CD19)
Tafasitamab
|
1422527-84-1
|
|
|
10 mg
|
14640元
|
In-stock
|
詳細(xì)
|
|
2025/05/22
|
HY-P9981
|
|
TAFASITAMAB (ANTI-CD19)
Tafasitamab
|
1422527-84-1
|
|
|
25 mg
|
21840元
|
In-stock
|
詳細(xì)
|
|
2025/05/22
|
HY-P9981
|
|
TAFASITAMAB (ANTI-CD19)
Tafasitamab
|
1422527-84-1
|
|
|
50 mg
|
29400元
|
In-stock
|
詳細(xì)
|
|
2025/05/22
|
HY-P9981
|
|
TAFASITAMAB (ANTI-CD19)
Tafasitamab
|
1422527-84-1
|
|
|
100 mg
|
39480元
|
In-stock
|
詳細(xì)
|